Please try another search
For the six months ended 30 June 2015, ERBA Diagnostics Inc revenues decreased 22% to $10.8M. Net loss totaled $1.6M vs. income of $615K. Revenues reflect Domestic segment decrease of 17% to $9M, European segment decrease of 41% to $1.8M. Net loss reflects Domestic segment loss totaling $870K vs. income of $633K, European segment loss totaling $235K vs. income of $167K.
Period Ending: | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 |
---|---|---|---|---|
Total Revenue | 5.95 | 4.85 | 6.01 | 6.47 |
Gross Profit | 2.64 | 2.1 | 2.83 | 3.14 |
Operating Income | -0.43 | -0.67 | -0.28 | 0.35 |
Net Income | -0.55 | -1.02 | -0.29 | 0.13 |
Period Ending: | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 |
---|---|---|---|---|
Total Assets | 25.76 | 24.49 | 26.2 | 26.4 |
Total Liabilities | 9.28 | 7.53 | 7.98 | 7.96 |
Total Equity | 16.48 | 16.95 | 18.22 | 18.44 |
Period Ending: | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 |
---|---|---|---|---|
Period Length: | 6 Months | 3 Months | 12 Months | 9 Months |
Cash From Operating Activities | -2.16 | -0.15 | -0.54 | -1.67 |
Cash From Investing Activities | -0.34 | -0.29 | -1.25 | -0.4 |
Cash From Financing Activities | 1.55 | 0 | 0.43 | 0.4 |
Net Change in Cash | -0.95 | -0.49 | -1.48 | -1.74 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review